Ensidipine dosage instructions

Enasidenib is an oral, targeted inhibitor used to treat a specific type of acute myeloid leukemia (AML), which is a patient with Patients with newly diagnosed, refractory or relapsed AML with IDH2 (isocitrate dehydrogenase2) mutations. This leaflet will provide detailed information on the correct use, dosage and related precautions of ensidipine.

1. Usage and dosage:

Dose: The recommended dose of ensidipine is 100 mg once daily. The drug should be used under the guidance of a doctor.

Usage: Ensidipine should be taken by mouth, preferably at the same time each day. It can be taken with or without food.

Taking tablets: Tablets should be swallowed whole and not chewed, broken or crushed.

Missed dose: If you miss a dose, take your normal dose at the next dose time and do not take an extra dose on the same day.

2. Notes:

Doctor's Instructions: Patients should strictly follow the doctor's prescriptions and instructions and do not change the dosage of the drug or stop using it unless otherwise instructed by the doctor.

Monitoring: During treatment, doctors may regularly monitor the patient's hematological indicators, liver function and other related indicators to ensure the safety and effectiveness of the drug.

Interactions with other drugs: Before using ensidipine, patients should inform their doctor of all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Certain drugs may interact with ensidipine, affecting its efficacy or increasing the risk of adverse reactions.

Pregnancy and lactation: Patients should avoid becoming pregnant while taking ensidipine and use effective contraception during treatment. If the patient is pregnant or plans to become pregnant, the doctor should be informed immediately. Additionally, female patients should stop breastfeeding while receiving treatment.

Side effects: Ensidipine may cause some adverse reactions, such as nausea, vomiting, fatigue, headache, etc. If patients experience serious adverse reactions or allergic reactions, they should inform their doctor immediately.

Liver function monitoring: During treatment, doctors may periodically monitor patients' liver function because ensidipine may cause abnormal liver function.

3. Storage:

Storage conditions: Ensidipine should be stored in a cool, dry place away from direct sunlight and moisture.

Out of reach of children: Medicines should be stored out of reach of children to avoid accidental ingestion by children.

4. Obsolete:

Expired Medications: If medications are expired or no longer needed, they should be disposed of correctly. You can ask your local health care provider or drug take-back center for advice on how to safely dispose of expired or no longer needed medications.

Ensidipine is an oral targeted inhibitor used to treat certain types of AML. Patients should strictly follow the doctor's prescriptions and instructions, use the medicine correctly as directed, and receive regular monitoring and evaluation by the doctor. At the same time, patients should pay attention to possible side effects and inform their doctors in time so that the treatment plan can be adjusted in a timely manner. During treatment, effective communication and cooperation between doctors and patients are key to ensuring that treatment is safe and effective.